Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional

John Peterson1, Trevor Wilson1, Joshua Gruhl1

  • 1Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.

JMIR Cancer
|June 7, 2022
PubMed
Abstract

Insights

Individuals pursue alternative cancer therapies based on personal values and beliefs, often due to perceived inefficacy of conventional treatments. This impacts mortality risks associated with alternative cancer therapy choices.

Area of Science:

  • Oncology
  • Integrative Medicine
  • Health Psychology

Background:

  • Alternative cancer therapies are linked to higher mortality rates.
  • Limited understanding exists regarding patient motivations for choosing these therapies.

Purpose of the Study:

  • To describe motivations behind alternative cancer therapy use.
  • To determine if motivations vary based on the timing of therapy initiation (before or after conventional treatment).

Main Methods:

  • Analysis of 649 GoFundMe cancer campaigns (2011-2019).
  • Mixed methods approach including qualitative thematic analysis.
  • Categorization of campaigns by therapy timing and statistical comparison of motivational themes.

Main Results:

  • Concerns about conventional therapy efficacy were higher when conventional therapy was used first (63.3% vs 41.7%).
  • Individuals starting with alternative therapy more frequently cited natural/holistic values (49.3%), unorthodox cancer views (25.5%), spiritual beliefs (15.1%), perceived efficacy (19.1%), and distrust of pharmaceuticals (3.2%).

Conclusions:

  • Patient choices in alternative cancer treatments often align with personal values and beliefs, irrespective of scientific evidence.
  • Perceived ineffectiveness of conventional cancer therapy is a key driver for pursuing alternative options.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458